Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia (ACH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02055157
Recruitment Status : Completed
First Posted : February 5, 2014
Last Update Posted : December 7, 2018
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2, 2017
Actual Study Completion Date : October 2, 2017
Certification/Extension First Submitted : September 19, 2018